Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Gregory J. Kato, MD
Researcher Executive Director
1020 First Avenue
CSL Behring
King of Prussia, Pennsylvania, United States
Dr. Kato is a hematologist with an active translational research interest in sickle cell disease, especially disorders of the blood vessel wall that may contribute to pulmonary hypertension. He takes care of adults with sickle cell disease, and leads clinical and laboratory bench research to learn the causes of pulmonary hypertension and other forms of vascular dysfunction and to develop new treatments to improve or prevent it.
Dr. Kato’s research specialties have been in blood flow physiology studies, clinical trials and proteomic analysis of plasma to unravel new mechanisms contributing to complications of sickle cell disease and to the development of red blood cells in the bone marrow. He and his team have formulated a model to suggest that pulmonary hypertension, stroke, leg ulcers and priapism share features of vasculopathy and more severe hemolytic anemia, and that pain crisis, acute chest syndrome and avascular necrosis share evidence of poor blood circulation due to viscosity. These two groups overlap and are not completely distinct.
Related Content
-
2019 Cure Sickle Cell Initiative Annual Forum: Accelerating Scientific PrioritiesTuesday, November 19 - Thursday, Novembe...
-
Gene-Edited ‘Supercells’ Make Progress In Fight Against Sickle Cell DiseaseDoctors are reporting the first evidence...
-
Sensorineural Hearing Loss in Children With Sickle Cell DiseaseIntroduction: Sensorineural hearing los...
-
Swee Lay Thein, MB, BS, FRCP, FRCPath, DSSwee Lay Thein is the Chief of the Sickl...
-
Sickle Cell Disease CoalitionThe Sickle Cell Disease Coalition (SCDC)...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Carla JonesAnyone affected by sickle cell disease k...